The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1513
January 30, 2017
View Complete Issue         Table of Contents 2019 
Drug Interaction: Dabigatran (Pradaxa) and Statins
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Drug Interaction: Dabigatran (Pradaxa) and Statins
January 30, 2017 (Issue: 1513)
The results of a recently published study suggest that taking the oral direct thrombin inhibitor dabigatran etexilate (Pradaxa) with either simvastatin (Zocor, and others) or lovastatin (Altoprev, and others) increases the risk of major...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Drug Interaction: Dabigatran (Pradaxa) and Statins
Article code: 1513e
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.